Addition of a histone deacetylase inhibitor increases recombinant protein expression in Medicago truncatula cell cultures by Santos, Rita B. et al.
1SCIeNTIfIC REPORtS | 7: 16756  | DOI:10.1038/s41598-017-17006-9
www.nature.com/scientificreports
Addition of a histone deacetylase 
inhibitor increases recombinant 
protein expression in Medicago 
truncatula cell cultures
Rita B. Santos, Ana Sofia Pires & Rita Abranches  
Plant cell cultures are an attractive platform for the production of recombinant proteins. A major 
drawback, hindering the establishment of plant cell suspensions as an industrial platform, is the low 
product yield obtained thus far. Histone acetylation is associated with increased transcription levels, 
therefore it is expected that the use of histone deacetylase inhibitors would result in an increase in 
mRNA and protein levels. Here, this hypothesis was tested by adding a histone deacetylase inhibitor, 
suberanilohydroxamic acid (SAHA), to a cell line of the model legume Medicago truncatula expressing 
a recombinant human protein. Histone deacetylase inhibition by SAHA and histone acetylation 
levels were studied, and the effect of SAHA on gene expression and recombinant protein levels was 
assessed by digital PCR. SAHA addition effectively inhibited histone deacetylase activity resulting in 
increased histone acetylation. Higher levels of transgene expression and accumulation of the associated 
protein were observed. This is the first report describing histone deacetylase inhibitors as inducers 
of recombinant protein expression in plant cell suspensions as well as the use of digital PCR in these 
biological systems. This study paves the way for employing epigenetic strategies to improve the final 
yields of recombinant proteins produced by plant cell cultures.
Plant cell suspensions are coming to prominence in the Molecular Farming field as a platform for the production 
of high value molecules. They have several key advantages when compared to conventional production systems, 
such as the ability to perform post-translational modifications, the use of low cost culture medium and GMP 
compliance1. Unlike microbial cells, plant cells are able to perform the complex glycosylation needed for correct 
folding and activity of many proteins2. Due to cheaper growth conditions, plant cell suspension cultures offer a 
low-cost alternative to mammalian production systems. In addition, their controlled and confined growth using 
classical fermentation technology, which allows the implementation of GMP, overcomes regulatory issues con-
cerning the use of transgenic plants (reviewed in3).
Molecular Farming has come a long way since 1989, when work by Hiatt and colleagues4 was featured on 
the cover of Nature. Many of the improvements since then were made by transferring knowledge obtained by 
researchers working on bacterial and mammalian platforms. Although plant cell cultures present many advan-
tageous characteristics, the low final product yields that have been obtained to date remain the main drawback 
preventing this system from becoming a reliable production platform.
Efforts to reduce the overall cost of production in mammalian cell line systems have focused on increas-
ing the final production yields5. One of the strategies used is to supplement media with protein expression 
inducers such as valproic acid6,7, sodium butyrate8–10 and hydroxamic acids11. These inducers are described to 
increase recombinant mRNA and protein expression levels by acting as histone deacetylase inhibitors (HDACi). 
Histone deacetylases (HDACs) remove acetyl groups from histones and their activity is regulated in the cell by 
the availability of acetyl-CoA (acetyl group donor) and by the HDAC/HAT (histone acetyltransferase) ratio12. 
HDACi are known to block the activity of HDAC enzymes, resulting in the hyperacetylation of histones. In 
turn, acetylated histones associate less tightly with DNA, facilitating access of the transcriptional machinery 
and potentially leading to higher mRNA synthesis and protein expression13. HDAC enzymes are present from 
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prokaryotes to eukaryotes14 and it has been reported that their secondary structure, particularly around the 
enzyme’s DNA binding site, is highly conserved15. Some of these HDACi have recently been used as anti-cancer 
agents. Suberanilohydroxamic acid (SAHA) has been shown to arrest cancer cell growth, to induce autophagy 
and apoptosis, and to have an anti-proliferative activity16,17. The hydroxamic acid moiety of SAHA binds to the 
zinc ion located at the end of the catalytic tubular pocket18. The insertion of hydroxamic acids inside the catalytic 
pocket of a HDAC prevents binding of its natural substrates and thus results in inhibition of catalytic activity18,19. 
SAHA is described to inhibit HDAC classes I, II and IV from the RPD3-like superfamily17 and was the first 
HDACi approved by FDA for advanced cutaneous T-cell lymphoma cancer therapy20. In plants, these types of 
compounds have mainly been used for fundamental biology studies (Sodium Butyrate21,22, trichostatin A23–25 
and SAHA, also known as vorinostat26) and to our knowledge there is no report of the use of these compounds as 
inducers of recombinant protein expression in plant cell cultures.
Medicago truncatula cell suspensions have been developed recently as a Molecular Farming platform and we 
have demonstrated a high yield of recombinant protein production for a fungal protein27. However, when human 
recombinant proteins (erythropoietin and lipocalin-type prostaglandin D2 synthase) were produced, the same 
high yields were not observed28,29. For this reason, a novel approach to improve the final yields of human recombi-
nant proteins was designed, which involves the use of HDAC inhibitors. With this strategy, we intend to increase 
transgene expression levels by opening the chromatin through increased histone acetylation.
In this report, the potential of SAHA as a protein expression inducer in Medicago truncatula cell suspensions 
is addressed. Here, it is demonstrated, for the first time, that SAHA is able to increase the levels of expression of 
the human recombinant lipocalin-type prostaglandin D2 synthase (L-PGDS) produced by a stably transformed 
M. truncatula cell line. This protein has been chosen as a model since it is a glycosylated human protein that is 
involved in several physiological functions. It is localized in a variety of human tissues and is used as a molecular 
marker (reviewed in30). The effect of SAHA on histone acetylation and HDAC inhibition is also investigated.
Results and Discussion
Effect of adding SAHA on Medicago cell culture growth. The effect of SAHA on Medicago cell cul-
tures expressing L-PGDS was initially screened by assessing its impact on cell viability. Cell viability was moni-
tored by trypan blue dye exclusion. The addition of SAHA was tested on different days (0, 3 and 7) of growth as 
well as at different concentrations (2.5 and 5 µM). A cell culture without SAHA was also monitored as a control.
When SAHA was added at day 0, at 5 µM final concentration, cell viability dropped from around 90% to 60% 
on day 5 of growth. By day 14, cell viability decreased to 10%, suggesting that this concentration is unsuitable 
(Fig. 1). When SAHA was added at a lower concentration (2.5 µM), at day 0, cell viability decreased from 90% to 
70% on day 5 of growth, with about 50% viable cells on day 14. Addition of SAHA at the beginning of the exper-
iment appears to have a considerable effect on cell viability and cell division and the results are dose dependent. 
This might be due to lower cell density during early phases of growth, when compared to SAHA additions later 
on. The same effect is observed for mammalian cell cultures when this type of compound is used to induce pro-
tein expression, due to cell cycle arrest. Usually, inducers of protein expression are only added once a certain cell 
density has been attained31.
Due to the toxic effects observed when using a concentration of 5 µM SAHA, further experiments were per-
formed using a lower concentration (2.5 µM). In order to assess the effect of SAHA on recombinant L-PGDS 
protein production, two different time points for the addition of SAHA were tested (day 3 and day 7). When 
added on day 3, corresponding to the onset of exponential phase, SAHA did not have as severe a toxic effect as 
Figure 1. Cell viability tests performed using the trypan blue dye exclusion test throughout 14 days of culture. 
*p value ≤ 0.05; **p value ≤ 0.01; ***p value ≤ 0.001; statistical analysis represented by *follows the same color 
code as the graph. Error bars indicate S.E.M. for n = 6 (control) and n = 3 (SAHA).
www.nature.com/scientificreports/
3SCIeNTIfIC REPORtS | 7: 16756  | DOI:10.1038/s41598-017-17006-9
compared to that observed for addition on day 0 (Fig. 1). In fact, cell viability throughout growth was similar to 
that observed for the control without SAHA. Moreover, when SAHA was added on day 7 of growth (end of the 
exponential growth phase), the negative effect on cell viability was far greater than what was observed for addi-
tion on day 3. We hypothesize that an addition of SAHA at the end of the exponential growth phase might have a 
higher toxic effect due to a reduced rate of cell division and associated capacity to metabolize SAHA. Despite the 
decrease in cell viability following addition on day 7, the resulting protein production and gene expression levels 
were still assessed.
Analysis of L-PGDS gene expression. Two independent experiments were performed with SAHA added 
at different stages of growth; day 3 and day 7. The effect of SAHA on L-PGDS gene expression was analyzed by 
digital PCR. Digital PCR is a relatively new technique but there are already some reports describing its use in 
plant studies, namely for GMO quantification32 or in disease resistance33,34. In this report, digital PCR was chosen 
to study the expression of recombinant L-PGDS since the treatment with SAHA might affect the expression of 
any gene, even of the housekeeping genes that are usually used as an internal reference. The use of an internal 
reference would not be possible and digital PCR allows absolute quantification without the need for an internal 
control.
The QuantStudioTM 3D (QS3D) AnalysisSuiteTM software reads a digital PCR chip and assesses different 
parameters: the quality of the sample loading, the fluorescent signal from the positive PCR reactions and the 
background noise present in the chip reading. The chip quality is displayed by flags (green: good quality; yellow: 
medium quality–needs revision; red: poor quality) as seen on Figure S1. The loading quality is displayed by the 
continuous green color on the chip (see Figure S1B) and non-amplified and amplified reactions (yellow and blue, 
respectively) are also represented on chip (Figure S1A) and on scatter plots (Figure S1C).
In Figure S1, digital PCR data for three biological replicates of the same sampling point are shown and the 
scatter plot depicts the cluster of non-amplified and amplified reactions, which also allows for verification of the 
homogeneity of the results obtained. The QS3D AnalysisSuiteTM software takes into account the dilution factor of 
the sample in order to give a final value of copies per µL.
When SAHA was added, at either day 3 or day 7, the expression of the recombinant L-PGDS gene increased 
(Fig. 2). At day 11 there was no significant difference in transgene expression between the culture induced on 
day 3 and that induced on day 7. When compared to the control culture, transgene expression increased 1.9-fold 
(SAHA addition on day 3) and 2.2-fold (SAHA addition on day 7) for samples taken on day 11 of growth. The 
increase in gene expression is consistent with the observations made in mammalian cell cultures, where SAHA 
is considered a protein expression inducer35. The recombinant L-PGDS protein expression was thus assessed.
Screening of recombinant protein levels. The production of recombinant L-PGDS, throughout growth, 
was assessed by western blotting. Addition of SAHA on day 3 resulted in higher accumulation of L-PGDS in the 
growth medium, compared with the control culture. This higher accumulation was observed two days after addi-
tion of the inducer of protein expression, with a 5-fold increase compared to the control (Fig. 3A). Accumulation 
of L-PGDS protein was also higher for these conditions on day 11, however by this point, the increase was only 
2.4-fold when compared to the control. This might be due to degradation of proteins by proteases present in 
the cell medium (Santos et al. in preparation). On the other hand, when SAHA was added on day 7 of growth, a 
2-fold decrease in L-PGDS accumulation in Medicago cell medium was observed three days after the addition. 
Figure 2. Gene expression analysis of Medicago cell lines expressing L-PGDS, with and without addition 
of 2.5 µM SAHA (at days 3 or 7 of growth). The calculated sample quantity (Copies/µL) represents the 
concentration of the cDNA sample in the PCR reaction mix. ***p value ≤ 0.001. Error bars indicate the 
theoretical confidence interval based on Poisson distribution calculated by the QS3D Analysis SuiteTM software 
for n = 6 (control) and n = 3 (SAHA).
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We hypothesized that this could be due to intracellular accumulation of L-PGDS protein. In order to assess this 
possibility, the levels of intracellular L-PGDS were investigated.
The amount of intracellular L-PGDS protein detected, when SAHA was added on day 3 of growth, was similar 
(day 5 and 11) or lower (day 7) than the control (see Fig. 4A and B). Despite a surge in protein production, the 
recombinant protein follows the secretory pathway, and is mostly released to the culture medium. However, when 
SAHA was added at day 7 of the growth, the surge in protein production led to the retention of L-PGDS protein 
inside the cell (see Fig. 4A and C), justifying the low levels of recombinant protein found in the cell medium. This 
accumulation was unforeseen given that the L-PGDS gene construct possesses a signal peptide that targets the 
protein to the secretory pathway. It has been described that under conditions of protein production peaks, the 
endoplasmic reticulum might become overloaded, which can result in greater intracellular accumulation of the 
recombinant protein36. Furthermore, stress or production of defective proteins might lead to unexpected sub-
cellular protein sorting37. This phenomenon has already been described in mammalian cell cultures producing 
recombinant proteins. To overcome this, lower cell incubation temperatures are used to increase the expression 
of specific proteins. Lower temperatures could increase folding capacity and the expression of endoplasmic retic-
ulum chaperones, which would ensure the recombinant proteins follows the secretory pathway and is exported to 
the medium38. Other studies suggest that the increase of recombinant protein production in CHO cells, following 
Figure 3. L-PGDS relative protein expression levels in cell medium. (A) Relative expression of L-PGDS with 
and without 2.5 µM SAHA throughout Medicago growth obtained from (B) western blot analysis of biological 
replicates of cell culture samples treated with SAHA on day 3 of growth and (C) on day 7 of growth with anti 
L-PGDS antibody. Control experiment lanes: 3, C5, C7 and C11. **p value ≤ 0.01; ***p value ≤ 0.001. Error 
bars indicate S.E.M. for n = 3. Full-length gels and immunoblots are shown in Supplementary Figure S2.
Figure 4. L-PGDS relative protein expression levels in cell extracts. (A) Relative expression of L-PGDS with 
and without 2.5 µM SAHA throughout Medicago cell growth obtained from (B) western blot analysis of cell 
extract samples treated with SAHA on day 3 of growth and (C) on day 7 of growth, with anti L-PGDS antibody. 
Control experiment lanes: 3, C5, C7 and C11. **p value ≤ 0.01. Error bars indicate S.E.M. for n = 3. Full-length 
gels and immunoblots are shown in Supplementary Figure S3.
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HDACi treatment at 33 °C (a lower temperature than the usually used), can be the result of elevated cellular secre-
tory capacity39,40. The combination of these two strategies could be easily implemented in plant cell suspension 
cultures in order to further increase recombinant protein production.
Histone deacetylase (HDAC) activity assay. Since transgene expression and recombinant protein levels 
increased in the presence of 2.5 µM SAHA, an in vitro assay was performed in order to confirm that this increase 
was correlated with HDAC inhibition by SAHA.
For this in vitro assay, nuclear extracts prepared from cells recovered at day 11 of M. truncatula culture 
were used. It is noteworthy that 2.5 µM SAHA was able to inhibit 74% (calculated using equation (1)) of the 
HDAC activity in Medicago samples. If HDACs are inhibited, fewer proteins become deacetylated. The amount 
of deacetylated histone was 2-fold lower in comparison to the control in the presence of SAHA (Fig. 5). This 
was important to evaluate since there are compounds that are able to inhibit mammalian HDACs but not plant 
HDACs. For instance, it has been described that sodium butyrate is a HDAC inhibitor in mammalian cells leading 
to histone hyperacetylation41. This compound was tested in alfalfa cells by Waterborg and colleagues, who con-
cluded that it fails to inhibit alfalfa HDACs since it is readily metabolized into acetyl-CoA, which is then incorpo-
rated in acetylated histones42,43. The results we obtained from in vitro experiments confirmed that SAHA is able to 
inhibit the activity of M. truncatula HDACs. However, inhibiting HDACs activity does not correlate directly with 
histone acetylation since non-histone proteins can also be subjected to their deacetylase activity44. Due to this, the 
level of histone acetylation was also assessed.
Analysis of histone H3 acetylation levels. The level of histone acetylation was determined by immu-
noblotting. Cell extracts were recovered along growth after the addition of SAHA at different days and the level 
of histone H3 acetylation was assessed.
Histone H3 was chosen to study acetylation levels since it has been described as the main target of acetylation 
in plants, in contrast with mammalian cells and fungi where acetylation is mainly observed on histone H443,44. 
Since HDACs have different specificity for different lysines45, total histone H3 acetylation levels were studied and 
normalized to histone H3 protein levels.
An increase of histone H3 acetylation levels was observed 2 to 3 days after addition of SAHA in both experi-
ments. When SAHA was added on day 3 of growth, a 1.6-fold increase of acetylation was observed. This increase 
was maintained throughout growth, with a 1.4-fold increase of acetylation levels observed on day 11 (see Fig. 6A). 
Addition of SAHA on the 7th day of growth resulted in a 3.1-fold increase of acetylation levels on day 11 (see 
Fig. 6A).
The analysis of histone H3 acetylation levels confirms that SAHA is able to inhibit HDAC activity in vitro 
(Fig. 5) and this inhibition leads to the accumulation of acetyl groups in histone H3 lysines.
Conclusion
This report describes for the first time the use of a histone deacetylase inhibitor for the improvement of recombi-
nant protein production in plant cell suspension cultures.
The effect of SAHA addition to Medicago truncatula cell culture was assessed at different growth stages. 
Although some degree of cell toxicity was observed, in a dose dependent manner, SAHA addition at day 3 and 
day 7 resulted in an increase of recombinant protein accumulation. When SAHA was added on day 7, protein 
was found to accumulate inside of the cells, rather than being secreted to the medium. This diversion from the 
targeted destination can result from an ER stress response, triggered by the synthesis of high amounts of recom-
binant proteins, and can lead to unexpected intracellular protein sorting46,47.
Figure 5. Inhibition of HDAC enzymatic activity. Amount of deacetylated product without and with SAHA. 
Error bars indicate S.E.M. for n = 3. *p value ≤ 0.05.
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This report also demonstrates for the first time, to our knowledge, the use of digital PCR with plant cell cul-
ture samples. With this technique, it was possible to observe that addition of SAHA had a stimulatory effect on 
L-PGDS transgene expression and associated protein production, resulting in the accumulation of protein up to 
5-fold higher than the control experiment. To prove the hypothesis that the addition of SAHA increases L-PGDS 
protein production by inhibiting HDACs and, therefore, increasing histone acetylation levels, the percentage of 
HDAC inhibition by SAHA was assessed. It was demonstrated for the first time that SAHA inhibits the activity 
of Medicago truncatula HDACs, which results in increased Histone H3 acetylation. Furthermore, the increase of 
histone H3 acetylation is concurrent with an increase in gene expression and of protein accumulation.
This work lays the first stone for the use of epigenetic modulation as a biotechnology tool to increase the yield 
of recombinant protein production in plant cell suspension cultures.
Material and Methods
Plant material, growth conditions and treatment with HDAC inhibitor. Medicago truncatula 
cell suspension cultures producing human lipocalin-type prostaglandin D2 synthase (L-PGDS)28 were grown 
in Murashige and Skoog medium (Duchefa, The Netherlands) supplemented with 30 g/L sucrose (Duchefa, The 
Netherlands), 4.65 μM kinetin (Duchefa, The Netherlands), 4.52 μM 2.4-D (Sigma-Aldrich, USA) and 65 μM 
dithiothreitol (Sigma-Aldrich, USA) at pH 5.8, in an orbital shaker (24 °C, 125 rpm) in the dark.
Experiments were established starting by subculturing a two-week old culture. Then, different SAHA concen-
trations were added at different time points (day 0, 3 and 7) of the culture growth and 2.5 μM SAHA was used for 
the following experiments. SAHA was added and for each time point biologic triplicates were prepared. SAHA 
solution was prepared in DMSO (Sigma-Aldrich, USA), which we previously verified did not affect cell growth. 
Spent medium was collected by vacuum filtration on days 3, 5, 7 and 11 from cultures with and without SAHA 
and stored at −20 °C.
Cell viability tests. Cell viability was assessed by dye exclusion (indicative of an intact membrane) using 
0.4% trypan blue in PBS-T (Sigma-Aldrich, USA) (1 volume of cells: 1 volume of trypan blue). Live cells with 
intact membranes are distinguished by their ability to exclude dyes that easily penetrate dead or damaged cells. 
For each experiment, biologic replicates of all time points were analyzed (six for control experiments and three 
for SAHA experiments) and the ratio between live and total cells was determined by hemacytomer cell count 
distributions. A minimum of 50 cells were obtained for cell counting of each replicate. The average percentage of 
live cells and S.E.M. were calculated.
Screening of recombinant L-PGDS production. Western blot analysis was performed with spent 
medium and cell extract samples collected during cell culture growth. Medium samples were 10-fold concentrated 
using centrifugal filtration units with 10 kDa cut-off Amicon Ultra-15 (Millipore, USA). Cells were ground using 
liquid nitrogen and a mortar. Extraction buffer (100 mM ascorbic acid, 500 mM NaCl, 5 mM β-mercaptoethanol, 
pH 8.0) was added to ground cells in 1:1 ratio (g of cells: mL of extraction buffer). Samples were resolved in a 
12.5% SDS-PAGE gel and proteins were transferred to a nitrocellulose membrane (0.2 µm, Amersham, UK). The 
membrane was blocked with 5% skimmed milk powder (Nestlé, Switzerland) and 3% BSA (NZYTech, Portugal) 
in PBS-T, for 1 hour at room temperature with gentle shaking, followed by incubation with 1:500 anti-L-PGDS 
(Ab 61866, Abcam, UK) in PBS-T, overnight at 4 °C. Then, the membrane was incubated with 1:8000 HRP con-
jugated anti-rabbit (A0545, Sigma-Aldrich, USA) in PBS-T, for 2 hours at room temperature with gentle shaking. 
Signal was detected by chemiluminescence using Amersham ECL Prime reagent (GE Healthcare Life Sciences, 
UK) in ChemiDoc™ XRS + System (Bio-Rad, USA). Three biological replicates were analyzed and western blots 
repeated three times.
Figure 6. Histone H3 relative acetylation levels. (A) Relative acetylation level of histone H3 with and without 
2.5 µM SAHA throughout Medicago culture growth obtained from (B) western blot analysis of cell extract 
samples treated with SAHA on day 3 of growth and (C) on day 7 of growth, with anti-acetyl-histone H3 and 
anti-histone H3 antibodies. Control experiment lanes: 3, C5, C7 and C11. *p value ≤ 0.05; **p value ≤ 0.01; 
***p value ≤ 0.001. Error bars indicate S.E.M. for n = 3. Full-length gels and immunoblots are shown in 
Supplementary Figure S4.
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Analysis of Histone H3 acetylation levels. Cell extracts were taken from cells recovered by vacuum 
filtration at day 3, 5, 7 and 11 of growth, as already described. Total protein extracts were resolved in a 15% 
SDS-PAGE gel and proteins were transferred to a nitrocellulose membrane (0.2 µm, Amersham, UK). The mem-
brane was blocked with 5% BSA (NZYTech, Portugal) in PBS-T for one hour at room temperature, with gentle 
shaking, followed by an overnight incubation with 1:5000 anti-acetyl-histone H3 (06–599, Merck Millipore, USA) 
in PBS-T, at 4 °C with gentle shaking. Then, the membrane was incubated in 1:8000 anti-rabbit HRP conju-
gated (A0545, Sigma-Aldrich, USA) for two hours in agitation at room temperature. Acetyl-histone H3 bands 
were detected using Amersham ECL Prime reagent (GE Healthcare Life Sciences, UK) and Hyperfilm ECL (GE 
Healthcare Life Sciences, UK) in a dark room. Then, the membrane was stripped, by washing five times with 
PBS-T buffer for 30 minutes each. Before reprobing with anti-histone H3 antibody, the membrane was incubated 
with the secondary antibody anti-rabbit-HRP in order to ensure that the stripping procedure was correctly per-
formed. If no signal was detected, the membrane was washed three times for 5 minutes each with PBS-T and 
incubated with 1:25000 anti-histone H3 (07–690, Merck Millipore, USA) in PBS-T, at 4 °C, overnight, with gentle 
shaking. Following incubation for two hours in agitation at room temperature with 1:8000 anti-rabbit HRP con-
jugated, histone H3 was detected as already described for acetyl-histone H3. Western blots were repeated three 
times.
Relative quantification of recombinant L-PGDS and levels of acetylated histone H3 was performed using FIJI 
software48 based on the relative intensity of bands49.
Immunoblots of L-PGDS, acetylated histone H3 and histone H3 were performed using the protocol described 
in50 in which several SDS-PAGE gel strips are organized in a single nitrocellulose membrane. This allows a correct 
quantitative comparison between samples on different gels or immunoblots by simultaneous transfer and detec-
tion of several samples in the same membrane.
Nuclei isolation and extraction. Control Medicago cells were harvested by vacuum filtration at day 11 
of growth as described above. Cells were ground with liquid nitrogen in a mortar. Ground cells were homog-
enized with cytoplasmic extraction buffer (25 mM Tris-HCl pH 6.5, 0.45 M sucrose, 5 mM MgCl2, 5 mM 
β-mercaptoethanol, 0.5 mM PMSF, 0.364 µM Pepstatin A, 1.2 µM E64, 0.1% Triton X-100) in a 1:4 ratio (g of 
cells: mL of cytoplasmic extraction buffer). The homogenate was filtered with a nylon mesh, followed by several 
filtration steps with decreasing pore size filters (150 µm, 100 µm, 50 µm and 30 µm, Sysmex-Partec, Germany). To 
pellet the nuclei, the 30 µm filtrate was centrifuged for 5 minutes at 4000 g and the pellet washed with cytoplas-
mic extraction buffer without 0.1% Triton X-100 (adapted from51). The pellet was then resuspended in 100 µL of 
nuclei extraction buffer (50 mM HEPES pH 5.7, 420 mM NaCl, 0.5 mM EDTANa2, 0.1 mM EGTA, 10% glycerol) 
and sonicated for 30 seconds (Bioruptor® Plus Sonication System, Diagenode, Belgium). After incubation on 
ice for 30 minutes, the homogenate was centrifuged at 11000 g for 10 minutes and the pellet was discarded. Total 
soluble protein was determined using the Bradford Protein Assay (Bio-Rad, USA) following the manufacturer’s 
instructions. Nuclear extractions were stored at −80 °C until use.
Histone deacetylase (HDAC) activity assay. The inhibition of HDACs activity by 2.5 µM SAHA was 
assessed with EpiQuick HDAC Activity/inhibition Assay Kit (Epigentek, USA), according to the manufacturer’s 
instructions. Briefly, nuclear extracts, prepared as described above, were incubated for 90 minutes, at 37 °C, with a 
HDAC specific substrate, in the presence or absence of SAHA. Capture antibody was added and incubated for one 
hour at room temperature. Then, detection antibody was added and incubated at room temperature for 30 min-
utes. Technical triplicates were analyzed. Total HDAC inhibition was determined by reading the absorbance at 
450 and 655 nm and calculated using the following formula (equation (1)):


 −
−
−



×
Inhibitor Sample OD Blank OD
No Inhibitor Sample Blank OD
1 100%
(1)
RNA isolation from Medicago cell samples. Total RNA was isolated from cell samples, with and with-
out 2.5 µM SAHA treatment, recovered at days 3, 5, 7 and 11 of the cell growth, with biological triplicates. Cell 
samples were obtained by vacuum filtration, flash-frozen in liquid nitrogen and stored at −80 °C until RNA 
isolation was performed. Cell samples were ground with eppendorf pestles in the presence of 500 µL of TRIzol 
reagent (NZYTech, Portugal). Next, Direct-zolTM RNA MiniPrep (Zymo Research, USA) was used to perform 
RNA isolation as indicated by manufacturer’s instructions. RNA sample concentrations were measured in a 
NanoDrop 2000c UV-Vis Spectrophotometer (Thermo Scientific, USA) and run in a 0.8% agarose gel to check for 
RNA integrity. Genomic DNA contamination in RNA samples was assessed by performing a PCR with primers 
designed for promoter and terminator of L-PGDS gene. RNA samples were negative for genomic DNA contami-
nation. Samples were flash-frozen in liquid nitrogen and stored at −80 °C until use.
cDNA synthesis. 500 ng of isolated RNA was used to synthesize cDNA using the ImProm-IITM Reverse 
Transcription System (Promega, USA), according to the manufacturer’s instructions. 0.5 µg of oligo(dT) and ran-
dom primers (Promega, USA) were used for each reaction. Briefly, RNA and primers were mixed and incubated 
at 70 °C for 5 minutes and placed on ice for a further 5 minutes. Then, the master mix was added to the previous 
reaction, to a final volume of 20 µL. The reactions were transferred to a thermocycler (Mastercycler, Eppendorf, 
Germany) and incubated as follows: 25 °C for 5 minutes, 42 °C for one hour, 70 °C for 15 minutes and then on hold 
at 4 °C. cDNA samples were stored at −20 °C until use.
QuantStudioTM 3D Digital PCR. The QuantStudioTM 3D Digital PCR (QS3D; Applied Biosystems, 
ThermoFischer Scientific, USA) was used to quantify L-PGDS gene expression in the cell samples in the presence 
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and absence of 2.5 µM SAHA. 0.005 ng to 0.25 ng of cDNA were used (so that final copies/µL value for each 
sample was within the range of 200 and 2000, as recommended by the manufacturer) and a TaqMan® probe 
(Hs00168748_m1 for human L-PGDS, ThermoFischer Scientific, USA) labeled with FAM was added to the 
QS3D master mix. Briefly, each QS3D chip was loaded with 14.5 µL of reaction (one chip per replicate) and 
sealed using a QS3D Chip Loader (ThermoFischer Scientific, USA), following the manufacturer’s instructions. 
The QS3D chips were loaded into a Dual Flat Bloc GeneAmpTM PCR System 9700 thermal cycler to perform 
amplification, with the following conditions: 96 °C for 10 minutes, 98 °C for 30 seconds and 60 °C for 2 minutes 
(both for 40 cycles) and hold at 25 °C (to avoid chip condensation). After amplification, chips were imaged on 
QS3D Instrument (ThermoFischer Scientific, USA) and data analysis was carried out in QS3D Analysis SuiteTM 
Software, which takes in account the samples dilution factor. The software applies a quantification algorithm 
based on the Poisson model and estimates copy number/µL mean values with a 95% confidence interval.
Statistical data analysis. All results obtained from cell viability, from relative quantification of proteins 
(L-PGDS, acetylated histone H3 and histone H3) and from the histone deacetylase activity assay were statistically 
analyzed by multiple t-tests (multiple comparisons using the Holm-Šídák method) with α = 0.05 (significance 
level). All statistical analysis was performed with GraphPad Prism version 6.0c for MacOS52. Statistical signifi-
cance was assumed for p values ≤0.05.
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